|
Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans Clinical research trials and Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans. Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "F" Clinical Trials Conditions > Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans  Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans
Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans
For Condition: Healthy,Obesity
Status: Completed
Sponsor(s): National Institute of Child Health and Human Development (NICHD) ,
Synopsis: Leptin is a hormone that acts in the body as a chemical messenger. It is produced in fat cells and is believed to regulate body weight in humans. Leptin decreases appetite and influences the energy balance of the body. This study will attempt to measure levels of leptin production in the fat pad of the body by using a process called microperfusion. Microperfusion works by inserting 2 to 3 probes (thin tubes) into the fat pad around the belly button. These probes can measure chemicals in an area known as the extracellular space. This is the small space between cells and blood vessels that hormones, medicines, nutrients, and salts travel through. The study will investigate the effects of a meal, insulin, glucose (sugar), and the medication isoproterenol on leptin levels. Researchers believe that leptin levels are regulated along with the enzyme, hormone sensitive lipase (HSL). When hormone sensitive lipase is activated fat is broken down in a process called lipolysis. In addition, increased levels of HSL result in decreased levels of leptin, which in turn increases appetite and food intake.
Details: The adipocyte hormone leptin serves as a humoral signal of energy stores, acting on central neuronal networks that regulate ingestive behavior and energy balance. The basis for the circadian rhythm and pulsatility of circulating leptin levels in the face of a relatively stable adipose mass is not known. We have already established the feasibility and validity of adipose tissue microperfusion in humans for measurements of leptin in adipose tissue interstitial fluid. The aim of this study now is to assess the specific aspects of the regulation of adipose tissue metabolism in situ. The hormone sensitive lipase (HSL) catalyzes the final, rate limiting step of energy mobilization from adipose tissue. Its activation results in hydrolysis of triglycerides, a process referred to as lipolysis. Increased HSL activity during fasting and stress, is physiologically coupled with significant reductions in circulating leptin levels, which in turn, results in increased food intake, and thus, restoration of energy balance. We hypothesize that local neural signals from the sympathetic nervous system to adipocytes through beta-adrenergic receptors simultaneously regulate leptin secretion and lipolysis, the latter via the modulation of HSL activity. This hypothesis will be tested by measurements of interstitial levels of leptin and glycerol in adipose tissue in situ before and after local administration of a beta-adrenergic agonist. Food intake and beta-adrenergic stimulation are excellent potential stimuli in the study of the novel fat-derived hormones, resistin and adiponectin. We hypothesize that insulin has regulatory effects on leptin secretion and lipolysis. This hypothesis will be tested by measurement of interstitial levels of leptin, TNF-alpha, and interleukin-6 in adipose tissue in situ and after local administration of insulin.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Healthy subjects ages 18 to 50 years. Healthy volunteers studied as outpatients. EXCLUSION CRITERIA Minors (less than 18 years of age) Subjects taking any medication on a regular basis. Individuals with hepatic, renal, HPA axis or thyroid dysfunction. Very lean individuals (defined as a body mass index less than 19). Smokers. Pregnant or lactating woman. Individuals with allergies to teflon, polyethylene or skin tape. Individuals with known allergy to isoproterenol. Individuals unable to abstain from alcohol, tobacco, tea, and coffee for 18 hours prior and during the study.
Total Enrollment: 70
Location and Contact Information:
National Institute of Child Health and Human Development (NICHD)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 980103; 98-CH-0103
Study Start Date: April 28, 1998
Record last reviewed: July 7, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001722
Other Healthy Studies:
1. Test of QLS Device to Detect Early Cataracts
2. Brain Receptors in Sympathetic Nervous System Regulation
3. Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers
4. Transcranial Magnetic Stimulation (TMS) Studies of Dystonia
5. Brain Imaging in Children With AD/HD
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans
|
|
|
|
|
|
|
|
